Medical Treatment of Acromegaly: Comorbidities and Their Reversibility by Somatostatin Analogs

Publisher： Karger

E-ISSN： 1423-0194|83|3-4|249-257

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.83, Iss.3-4, 2006-10, pp. : 249-257

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Medical Treatment of Acromegaly with Dopamine Agonists or Somatostatin Analogs

By  

Neuroendocrinology, Vol. 103, Iss. 1, 2016-0 ,pp. : 50-58

Karger

Access to resources Recommend Favorite

Somatostatin Analogue Treatment Increases AIP Protein Expression in Somatotroph Tumours from Patients with Acromegaly and in GH3 Cells in vitro

By  

Hormone Research in Paediatrics, Vol. 76, Iss. 1, 2011-07 ,pp. : 111-112

Karger

Access to resources Recommend Favorite

Treatment of Acromegaly

By  

Hormone Research in Paediatrics, Vol. 62, Iss. 3, 2004-11 ,pp. : 79-92

Karger

Access to resources Recommend Favorite

Medical Treatment of Cushing’s Disease: Somatostatin Analogues and Pasireotide

By  

Neuroendocrinology, Vol. 92, Iss. 1, 2010-09 ,pp. : 120-124

Karger

Access to resources Recommend Favorite

Pegvisomant Treatment in Acromegaly

By  

Neuroendocrinology, Vol. 103, Iss. 1, 2016-0 ,pp. : 59-65

Karger

Access to resources Recommend Favorite